- Leydig cell tumors
- Constitute 1 to 3 percent of testis tumors.
- Ten percent are malignant. They are never malignant in prepubertal patients.
- Malignancy is diagnosed by presence of metastases.
- Histologic determination of malignancy unreliable.
- Sertoli cell tumors
- Less than 1 percent of testis tumors.
- Ten percent are malignant (determined by presence of metastases).
References
- Baniel J, Foster RS, Rowland RG, Bihrle R, Donahue JP: Testis cancer: Complications of post-chemotherapy retroperitoneal lymph node dissection. J Urol 153:976-980, 1995.
- Donohue JP, Thornhill JA, Foster RS, Bihrle R, Rowland RG, Einhorn LH: The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: The Indiana University experience (1965 to 1989). J Urol 153:85-89, 1995.
- Einhorn LH: Salvage therapy for germ cell tumors. Semin Oncol 21:47-51, 1994.
- Einhorn LH, Donohue JP: Advanced testicular cancer: Update for urologists. J Urol 160:1964-1969. 1998.
- Moller H, Skakkeback NE: Testicular cancer and cryptorchidism in relation to prenatal factors: Case control studies in Denmark. Cancer Causes Control 8:904-12, 1997.
- Nichols C, Loehrer P Sr: The story of second cancers in patients cured of testicular cancer: Tarnishing success of burnishing irrelevance. J Natl Cancer Inst 89:1304-1305, 1997.
- Wegner HEH, Hubotter A, Andresen R, Miller K: Testicular microlithiasis and concomitant testicular intraepithelial neoplasia. Int Urol Nephrol 30:313-315, 1998.